Latigo Biotherapeutics Inc.
NASDAQ:LTGOMedical - Pharmaceuticals
Healthcare
$13.31 +5.43%
+$0.76 today
- Market cap
- $800.64M
- Beta
- 0.00
52W Low $13.50High $25.93
Volume 0.21M
Average 0.38M
LTGO Debt Repayment
Cash used to repay borrowings during the period.
No reported Debt Repayment figures are available to summarize.
Debt Repayment history
Currency unavailable · from the cash flow
No Debt Repayment data reported for this period type.
Debt Repayment vs competitors
How LTGO compares with its peers on the latest reported figures
LTGO Competitors
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $218.97M USD | -639.9% | -20.0% | 29.8% | |
| LTM Mar 2026 | $61.49M USD | -187.3% | — | 7.7% | |
| LTM Mar 2026 | $12.32M USD | +126.5% | -55.2% | 36.4% | |
LTGOLatigo Biotherapeutics Inc. | — | — | — | — | — |
| Peer median (excluding LTGO) | — | -187.3% | -37.6% | 29.8% | |
Competitors are the stored peer set for LTGO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Currency unavailable
Latigo Biotherapeutics Inc.
NASDAQ:LTGO
Intrinsic Alpha fair value
Locked
Current Price
$13.31
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.